切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2021, Vol. 08 ›› Issue (03) : 125 -129. doi: 10.3877/cma.j.issn.2095-7157.2021.03.008

综述

Barrett食管的内镜下治疗进展
张帅1, 刘迎娣1, 令狐恩强1,()   
  1. 1. 100853 北京,解放军总医院第一医学中心消化内科医学部
  • 收稿日期:2021-04-08 出版日期:2021-08-15
  • 通信作者: 令狐恩强

Progress in endoscopic treatment of barrett′s esophagus

Shuai Zhang1, Yingdi Liu1, Enqiang Linghu1,()   

  1. 1. Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China
  • Received:2021-04-08 Published:2021-08-15
  • Corresponding author: Enqiang Linghu
引用本文:

张帅, 刘迎娣, 令狐恩强. Barrett食管的内镜下治疗进展[J]. 中华胃肠内镜电子杂志, 2021, 08(03): 125-129.

Shuai Zhang, Yingdi Liu, Enqiang Linghu. Progress in endoscopic treatment of barrett′s esophagus[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2021, 08(03): 125-129.

Barrett食管是一种癌前病变,有发展为食管腺癌的风险,近年来其患病率呈逐渐增加的趋势。随着消化内镜技术的飞速发展,对Barrett食管的内镜下治疗有了更多的新手段和新认识。本文就Barrett食管内镜下治疗的最新进展做一综述。

Barrett′s esophagus is a kind of precancerous lesion, which has the risk of developing into esophageal adenocarcinoma. In recent years, the morbidity rate of Barrett′s esophagus is gradually increasing. With the rapid development of digestive endoscopy, there are more new methods and new knowledge of endoscopic treatment of Barrett′s esophagus. This article reviews the latest progress in endoscopic treatment of Barrett′s esophagus.

[1]
国家消化系统疾病临床医学研究中心,中华医学会消化内镜学分会,中国医师协会消化医师分会.中国巴雷特食管及其早期腺癌筛查与诊治共识(2017年,万宁)[J]. 中华消化内镜杂志201734(9):609-620.
[2]
van Soest EM,,Dieleman JP,,Siersema PD,et al. Increasing incidence of Barrett′s oesophagus in the general population[J]. Gut200554(8):1062-1066.
[3]
Shiota S,,Singh S,,Anshasi A,et al. Prevalence of Barrett′s Esophagus in Asian Countries:A Systematic Review and Meta-analysis[J]. Clin Gastroenterol Hepatol201513(11):1907-1918.
[4]
Naini BV,,Souza RF,,Odze RD. Barrett′s Esophagus:A Comprehensive and Contemporary Review for Pathologists[J]. Am J Surg Pathol201640(5):e45-66.
[5]
Schlemper RJ,,Riddell RH,,Kato Y,et al. The Vienna classification of gastrointestinal epithelial neoplasia[J]. Gut200047(2):251-255.
[6]
Sikkema M,,Looman CW,,Steyerberg EW,et al. Predictors for neoplastic progression in patients with Barrett′s Esophagus:a prospective cohort study[J]. Am J Gastroenterol2011106(7): 1231-1238.
[7]
Wani S,,Qumseya B,,Sultan S,et al. Endoscopic eradication therapy for patients with Barrett′s esophagus-associated dysplasia and intramucosal cancer[J]. Gastrointest Endosc201887(4):907-931.e9.
[8]
Shaheen NJ,,Falk GW,,Iyer PG,et al. ACG Clinical Guideline: Diagnosis and Management of Barrett′s Esophagus[J].Am J Gastroenterol2016111(1):30-50; quiz 51.
[9]
Desai M,,Saligram S,,Gupta N,et al. Efficacy and safety outcomes of multimodal endoscopic eradication therapy in Barrett′s esophagus-related neoplasia:a?systematic review and pooled analysis[J]. Gastrointest Endosc201785(3):482-495.e4.
[10]
Chadwick G,,Groene O,,Markar SR,et al. Systematic review comparing radiofrequency ablation and complete endoscopic resection in treating dysplastic Barrett′s esophagus:a critical assessment of histologic outcomes and adverse events[J]. Gastrointest Endosc201479(5):718-731.e3.
[11]
Pimentel-Nunes P,,Dinis-Ribeiro M,,Ponchon T, et al. Endoscopic submucosal dissection:European Society of Gastrointestinal Endoscopy (ESGE) Guideline[J]. Endoscopy201547(9): 829-854.
[12]
Martelli MG,,Duckworth LV,,Draganov PV.Endoscopic Submucosal Dissection Is Superior to Endoscopic Mucosal Resection for Histologic Evaluation of Barrett′s Esophagus and Barrett′s-Related Neoplasia[J]. Am J Gastroenterol2016111(6):902-903.
[13]
Swager AF,,Boerwinkel DF,,de Bruin DM,et al. Detection of buried Barrett′s glands after radiofrequency ablation with volumetric laser endomicroscopy[J]. Gastrointest Endosc201683(1):80-88.
[14]
Alvarez Herrero L,,Pouw RE,,van Vilsteren FG,et al. Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett′s esophagus[J]. Endoscopy201143(3):177-183.
[15]
Pouw RE,,Beyna T,,Belghazi K,et al. A prospective multicenter study using a new multiband mucosectomy device for endoscopic resection of early neoplasia in Barrett′s esophagus[J]. Gastrointest Endosc201888(4):647-654.
[16]
Peters FP,,Kara MA,,Curvers WL,et al. Multiband mucosectomy for endoscopic resection of Barrett′s esophagus:feasibility study with matched historical controls[J]. Eur J Gastroenterol Hepatol, 200719(4):311-315.
[17]
龙丹,王富华,曾锦荣,等. 透明帽法黏膜切除术与多环套扎黏膜切除术治疗早期食管癌及癌前病变的临床效果[J]. 慢性病学杂志202021(5):753-754; 757.
[18]
Fujiya M,,Tanaka K,,Dokoshi T,et al. Efficacy and adverse events of EMR and endoscopic submucosal dissection for the treatment of colon neoplasms:a meta-analysis of studies comparing EMR and endoscopic submucosal dissection[J]. Gastrointest Endosc2015, 81(3):583-595.
[19]
Yang D,,Zou F,,Xiong S,et al. Endoscopic submucosal dissection for early Barrett′s neoplasia:a meta-analysis[J]. Gastrointest Endosc201887(6):1383-1393.
[20]
Terheggen G,,Horn EM,,Vieth M,et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett′s neoplasia[J]. Gut201766(5):783-793.
[21]
Deprez PH,,Piessevaux H,,Aouattah T,et al. 587c:ESD in Barrett′s Esophagus High Grade Dysplasia and Mucosal Cancer:Prospective Comparison With CAP Mucosectomy[J]. Gastrointest Endosc201071(5).
[22]
Chedgy F,,Subramaniam S,,Kandiah K,et al. Tu1155 EMR vs ESD for Barrett′s Neoplasia:Time to shift the paradigm?[J]. Gastrointest Endosc201683(5):AB556-AB557.
[23]
Haidry R,,Lovat L,,Sharma P. Radiofrequency ablation for Barrett′s dysplasia:past,present and the future?[J]. Curr Gastroenterol Rep, 201517(3):1-6.
[24]
Phoa KN,,van Vilsteren FG,,Weusten BL,et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia:a randomized clinical trial[J]. Jama2014311(12):1209-1217.
[25]
Pouw RE,,Klaver E,,Phoa KN,et al. Radiofrequency ablation for low-grade dysplasia in Barrett′s esophagus:long-term outcome of a randomized trial[J]. Gastrointest Endosc202092(3):569-574.
[26]
Qumseya BJ,,Wani S,,Gendy S,et al. Disease progression in Barrett′s low-grade dysplasia with radiofrequency ablation compared with surveillance:systematic review and meta-analysis[J].Am J Gastroenterol2017112(6):849-865.
[27]
Rosmolen WD,,Phoa N,,Nieuwkerk PT,et al. Impact of ablation of Barrett′s esophagus with low-grade dysplasia on patients′ illness perception and quality of life:a multicenter randomized trial[J]. Gastrointest Endosc201990(2):215-221.
[28]
Sharma P,,Shaheen NJ,,Katzka D,et al. AGA Clinical Practice Update on Endoscopic Treatment of Barrett′s Esophagus With Dysplasia and/or Early Cancer Expert Review[J]. Gastroenterology2020158(3):760-769.
[29]
Phoa KN,,Pouw RE,,van Vilsteren FGI,et al. Remission of Barrett′s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection:a Netherlands cohort study[J]. Gastroenterology2013145(1):96-104.
[30]
Krajciova J,,Janicko M,,Falt P,et al. Radiofrequency Ablation in Patients with Barrett′s Esophagus-related Neoplasia - Long-Term Outcomes in the Czech National Database[J]. J Gastrointestin Liver Dis201928(1):149-155.
[31]
Guthikonda A,,Cotton CC,,Madanick RD,et al. Clinical Outcomes Following Recurrence of Intestinal Metaplasia After Successful Treatment of Barrett′s Esophagus With Radiofrequency Ablation[J]. Am J Gastroenterol2017112(1):87-94.
[32]
Gosain S,,Mercer K,,Twaddell WS,et al. Liquid nitrogen spray cryotherapy in Barrett′s esophagus with high-grade dysplasia: long-term results[J]. Gastrointest Endosc201378(2):260-265.
[33]
Gage AA,,Baust J. Mechanisms of tissue injury in cryosurgery[J]. Cryobiology199837(3):171-186.
[34]
Canto MI. Cryotherapy for Barrett′s Esophagus[J]. Gastrointest Endosc Clin N Am201727(3):503-513.
[35]
van Munster SN,,Overwater A,,Haidry R,et al. Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett′s esophagus: impact on treatment response and postprocedural pain[J]. Gastrointest Endosc201888(5):795-803.e2.
[36]
Dam AN,,Klapman J. A narrative review of Barrett′s esophagus in 2020, molecular and clinical update[J]. Ann Transl Med20208(17):1107-1107.
[37]
Hamade N,,Desai M,,Thoguluva Chandrasekar V,et al. Efficacy of cryotherapy as first line therapy in patients with Barrett′s neoplasia:a systematic review and pooled analysis[J]. Dis Esophagus201932(11):doz040.
[38]
Mohan BP,,Krishnamoorthi R,,Ponnada S,et al. Liquid Nitrogen Spray Cryotherapy in Treatment of Barrett′s Esophagus,where do we stand? A Systematic Review and Meta-Analysis[J].Dis Esophagus201932(6):doy130.
[39]
Canto MI,,Shin EJ,,Khashab MA,et al. Safety and efficacy of carbon dioxide cryotherapy for treatment of neoplastic Barrett′s esophagus[J]. Endoscopy201547(7):582-591.
[40]
Canto MI,,Trindade AJ,,Abrams J,et al. Multifocal Cryoballoon Ablation for Eradication of Barrett′s Esophagus-Related Neoplasia:A Prospective Multicenter Clinical Trial[J]. Am J Gastroenterol2020115(11):1879-1890.
[41]
Wronska E,,Polkowski M,,Orlowska J,et al.Argon plasma coagulation for Barrett′s esophagus with low-grade dysplasia:a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose[J]. Endoscopy202153(2):123-132.
[42]
Manner H,,Rabenstein T,,Pech O,et al. Ablation of residual Barrett′s epithelium after endoscopic resection:a randomized long-term follow-up study of argon plasma coagulation vs. surveillance(APE study)[J]. Endoscopy201446(1):6-12.
[43]
Peerally MF,,Bhandari P,,Ragunath K,et al. Radiofrequency ablation compared with argon plasma coagulation after endoscopic resection of high-grade dysplasia or stage T1 adenocarcinoma in Barrett′s esophagus:a randomized pilot study(BRIDE)[J]. Gastrointest Endosc201989(4):680-689.
[44]
Manner H,,May A,,Kouti I,et al. Efficacy and safety of Hybrid-APC for the ablation of Barrett′s esophagus[J].Surg Endosc201630(4):1364-1370.
[45]
Kashin SV,,Kuvaev R,,Nadezhin AS,et al. Mo2016 The New Hybrid Argon Plasma Coagulation(Hybrid APC) for Endoscopic Ablation of Barrett′s Esophagus(BE):the Results of the Pilot Trial[J]. Gastrointest Endosc201683(5):AB495.
[46]
Qumseya BJ,,David W,,Wolfsen HC. Photodynamic Therapy for Barrett′s Esophagus and Esophageal Carcinoma[J]. Clin Endosc, 201346(1):30-37.
[47]
Overholt BF,,Lightdale CJ,,Wang KK,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett′s esophagus:international,partially blinded,randomized phase III trial[J]. Gastrointest Endosc200562(4):488-498.
[48]
Grade AJ,,Shah IA,,Medlin SM,et al. The efficacy and safety of argon plasma coagulation therapy in Barrett′s esophagus[J]. Gastrointest Endosc199950(1):18-22.
[49]
Prasad GA,,Wang KK,,Buttar NS,et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett′s esophagus[J]. Gastroenterology2007132(4):1226-1233.
[50]
Van Laethem JL,,Peny MO,,Salmon I,et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett′s oesophagus[J]. Gut200046(4):574-577.
[51]
Gray NA,,Odze RD,,Spechler SJ.Buried metaplasia after endoscopic ablation of Barrett′s esophagus:a systematic review[J]. Am J Gastroenterol2011106(11):1899-1908; quiz 1909.
[52]
Overholt BF,,Wang KK,,Burdick JS,et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett′s high-grade dysplasia[J]. Gastrointest Endosc200766(3):460-468.
[1] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[2] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[3] 汪沛, 倪蓓君, 元及, 宫为一, 范军. 卡瑞利珠单抗联合卡铂和培美曲塞治疗进展期肺腺癌的疗效及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 511-513.
[4] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[5] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[6] 龙慧玲, 林蜜, 邵婷. 三维球体间充质干细胞培养技术的研究进展及其应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 229-234.
[7] 秦富豪, 郑正, 江滨. 间充质干细胞在克罗恩病肛瘘治疗中的研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(03): 172-177.
[8] 蔡晨, 龚伟. 免疫治疗在胆道肿瘤中的应用现状及展望[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 162-166.
[9] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[10] 侍新宇, 孙金兵, 何宋兵. 血液生物标志物在直肠癌新辅助治疗中的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 228-233.
[11] 任加发, 邬步云, 邢昌赢, 毛慧娟. 2022年急性肾损伤领域基础与临床研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 276-281.
[12] 何佳伟, 张良, 杨骐, 王占祥. 创伤性颅脑损伤后进展性出血性损伤的诊疗现状[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 175-179.
[13] 张坤淇, 张睿, 徐佳, 康庆林. 漂浮膝损伤的诊治进展[J]. 中华老年骨科与康复电子杂志, 2023, 09(04): 252-256.
[14] 黄文鹏, 邱永康, 杨琦, 宋乐乐, 陈钊, 范岩, 康磊. PET相关影像组学在肿瘤预后中的研究进展[J]. 中华消化病与影像杂志(电子版), 2023, 13(02): 104-110.
[15] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
阅读次数
全文


摘要